Indirect treatment comparison of interventions for Neovascular (WET) age-related macular degeneration (WET AMD)
Malcolm, W.A, Hodgson, R, Glanville, J, Barata, T, Fleetwood, K
Published in Value in health (01.05.2015)
Published in Value in health (01.05.2015)
Get full text
Journal Article
The Budget Impact of Introducing Ranibizumab in England and Wales for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Malcolm, W.A, Leteneux, C, Claxton, L, Taylor, M, Rathi, H
Published in Value in health (01.11.2013)
Published in Value in health (01.11.2013)
Get full text
Journal Article
PSS2 - Indirect treatment comparison of interventions for Neovascular (WET) age-related macular degeneration (WET AMD)
Malcolm, W.A., Hodgson, R., Glanville, J., Barata, T., Fleetwood, K.
Published in Value in health (01.05.2015)
Published in Value in health (01.05.2015)
Get full text
Journal Article
PSS22 - Cost-Effectiveness of Ranibizumab for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia in the United Kingdom
Leteneux, C., Claxton, L., Malcolm, W.A., Taylor, M., Rathi, H.
Published in Value in health (01.11.2013)
Published in Value in health (01.11.2013)
Get full text
Journal Article
PSS9 - The Budget Impact of Introducing Ranibizumab in England and Wales for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Malcolm, W.A., Leteneux, C., Claxton, L., Taylor, M., Rathi, H.
Published in Value in health (01.11.2013)
Published in Value in health (01.11.2013)
Get full text
Journal Article